Healthcare & Life Sciences
Pain Management Practice Acquirers: Strategics, Private Equity, MSOs, and Spine Platforms
ByAuxo Capital AdvisorsSeptember 6, 2026
A seller-focused guide to pain management practice buyers and acquirers, including strategic healthcare platforms, regional pain consolidators, private equity-backed MSOs, spine and musculoskeletal platforms, health systems, independent sponsors, and other capital providers; buyer fit, procedure mix, referral and payer durability, provider transferability, controlled-substance and ASC diligence, financing certainty, information staging, offer comparison, integration risk, and seller proceeds.
Read More Pain Management Practice Acquirers: Strategics, Private Equity, MSOs, and Spine Platforms
Healthcare & Life Sciences
Pain Management M&A: Why Interventional Pain and Spine Practices Attract Acquirers
ByAuxo Capital AdvisorsSeptember 6, 2026
A buyer-underwriting guide to pain management practice M&A, including interventional pain and spine practices, procedure mix, referral durability, payer exposure, ASC adjacency, private equity demand, diligence risk, and seller readiness.
Read More Pain Management M&A: Why Interventional Pain and Spine Practices Attract Acquirers
Healthcare & Life Sciences
Pain Management Valuation Multiples: EBITDA, Procedure Mix, Referral Sources, and Acquirer Demand
ByAuxo Capital AdvisorsSeptember 6, 2026September 20, 2026
A buyer-underwriting guide to pain management valuation multiples, including accepted EBITDA, procedure mix, referral durability, payer exposure, provider productivity, ASC economics, compliance, acquirer demand, financing constraints, diligence sensitivity, and seller proceeds.
Read More Pain Management Valuation Multiples: EBITDA, Procedure Mix, Referral Sources, and Acquirer Demand
Healthcare & Life Sciences
Pain Management Practice Valuation: What Is an Interventional Pain Practice Worth?
ByAuxo Capital AdvisorsSeptember 6, 2026
A buyer-underwriting guide to pain management practice valuation, including procedure mix, referral durability, payer exposure, provider productivity, ASC adjacency, controlled-substance compliance, reported-to-normalized-to-buyer-accepted EBITDA, cash conversion, valuation methods, financing constraints, enterprise value, equity value, and seller proceeds.
Read More Pain Management Practice Valuation: What Is an Interventional Pain Practice Worth?
Healthcare & Life Sciences
How to Sell a Pain Management Practice: Valuation, Acquirers, and Exit Planning
ByAuxo Capital AdvisorsSeptember 6, 2026September 13, 2026
A seller-focused guide to selling a pain management practice, including owner objectives, sale readiness, normalized earnings, procedure mix, referral and payer durability, controlled-substance compliance, ASC adjacency, confidential buyer outreach, IOI and LOI comparison, diligence, working capital, seller proceeds, closing, and physician transition.
Read More How to Sell a Pain Management Practice: Valuation, Acquirers, and Exit Planning
Healthcare & Life Sciences
Private Equity in Pain Management: Why Sponsors Invest in Interventional Pain and Spine Platforms
ByAuxo Capital AdvisorsSeptember 6, 2026
A sponsor-underwriting guide to private equity in pain management, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, cash conversion, referral and payer durability, ASC adjacency, controlled-substance and compliance risk, leverage, financing, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.
Read More Private Equity in Pain Management: Why Sponsors Invest in Interventional Pain and Spine Platforms
Healthcare & Life Sciences
Physical Therapy Practice Acquirers: Strategics, Private Equity, MSOs, and Rehab Platforms
ByAuxo Capital AdvisorsAugust 30, 2026
A buyer-underwriting guide to physical therapy practice acquirers, including strategic operators, PE-backed rehab platforms, MSOs, regional consolidators, buyer fit, clinician and referral transferability, financing, diligence, offer comparison, closeability, and seller outcomes.
Read More Physical Therapy Practice Acquirers: Strategics, Private Equity, MSOs, and Rehab Platforms
Healthcare & Life Sciences
How to Sell a Physical Therapy Practice: Valuation, Acquirers, and Exit Planning
ByAuxo Capital AdvisorsAugust 30, 2026
A seller-focused guide to selling a physical therapy practice, including owner objectives, sale readiness, buyer-accepted EBITDA, clinic and clinician evidence, buyer qualification, confidentiality, IOI and LOI comparison, diligence, working capital, financing, seller proceeds, closing, and transition.
Read More How to Sell a Physical Therapy Practice: Valuation, Acquirers, and Exit Planning
Healthcare & Life Sciences
Physical Therapy Valuation Multiples: EBITDA, Clinic Density, Referral Mix, and Acquirer Demand
ByAuxo Capital AdvisorsAugust 30, 2026
An in-depth guide to physical therapy valuation multiples, including buyer-accepted EBITDA, clinic density, referral and payer mix, clinician productivity, platform quality, diligence risk, and seller proceeds.
Read More Physical Therapy Valuation Multiples: EBITDA, Clinic Density, Referral Mix, and Acquirer Demand
Healthcare & Life Sciences
Physical Therapy Practice Valuation: What Is a PT Clinic Worth?
ByAuxo Capital AdvisorsAugust 30, 2026
An in-depth guide to physical therapy practice valuation, including buyer-accepted EBITDA, clinic-level economics, payer and referral risk, valuation methods, and the bridge from enterprise value to seller proceeds.
Read More Physical Therapy Practice Valuation: What Is a PT Clinic Worth?